John Ronald Zysk
University of Virginia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by John Ronald Zysk.
Peptides | 1986
Michael J. Cronin; John Ronald Zysk; Alex J. Baertschi
The hypophysiotrophic hormone corticotropin releasing factor (CRF) stimulates the anterior pituitary corticotroph to export stress hormones such as adrenocorticotrophic hormone (ACTH). In rat anterior pituitary cells, CRF-induced elevation of cyclic AMP was profoundly potentiated (by an order of magnitude) by stimulators of protein kinase C. This effect occurred within minutes, was concentration dependent, and exhibited the appropriate pharmacological specificity to attribute the effects to protein kinase C. Phorbol myristate acetate (PMA), phorbol dibutyrate (PDB) and teleocidin were active with appropriate EC50s, while 4-alpha-PMA was inactive. PMA and PDB were also ACTH secretagogues in their own right. We suggest that protein kinase C can modulate CRF receptor coupling to the adenylate cyclase holoenzyme in anterior pituitary cells.
Molecular and Cellular Endocrinology | 1989
Reinhard W. Holl; Michael O. Thorner; John Ronald Zysk; Denis A. Leong
Free cytosolic calcium concentration, [Ca2+]i, in single rat pituitary cells can be measured with the fluorescent, calcium-sensitive probe fura-2 and digital image analysis. A reverse hemolytic plaque assay (RHPA) identifies somatotropes in the mixed population of pituitary cells. Previous studies showed that growth hormone releasing factor (GRF) stimulates growth hormone (GH) release from pituitary somatotropes by increasing the influx of calcium into the cell. Somatostatin reduced [Ca2+]i and inhibits hormone release presumably by closing calcium channels in the membrane. The calcium-ionophore bromo-A23187 rapidly increased [Ca2+]i from a baseline of 226 +/- 38 nM to a peak of 842 +/- 169 nM (mean +/- SEM) which was reached 30 s after exposure to the drug. This spike was followed by a sustained phase of elevated [Ca2+]i approximately 370 nM. When somatostatin (SRIF) (10 nM) was combined with ionophore treatment, the initial rise was preserved. However, the second phase was abolished and SRIF lowered [Ca2+]i to 57 +/- 7 nM. Depolarizing the cellular membrane with high extracellular potassium (60 mM) increased cytosolic calcium as well (797 +/- 178 nM); however, this was not affected by the addition of SRIF (988 +/- 71 nM). KCl depolarization in calcium-free medium (+1.5 mM EGTA) provoked no rise in cytosolic calcium. In contrast, after ionophore, the initial spike was preserved while the sustained phase of elevated [Ca2+]i was abolished. We conclude from these data that (1) membrane depolarization and ionophore treatment lead to an influx of calcium into the cytosol of normal pituitary somatotropes. (2) SRIF inhibits calcium influx induced by ionophore but not influx after depolarization with high potassium concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)
Molecular Endocrinology | 1993
Bruce D. Gaylinn; Jeffrey K. Harrison; John Ronald Zysk; Charles E. Lyons; Kevin R. Lynch; Michael O. Thorner
Endocrinology | 1994
Bruce D. Gaylinn; Charles E. Lyons; John Ronald Zysk; I J Clarke; Michael O. Thorner
Archive | 1993
William R. Baumbach; John Ronald Zysk; Michael O. Thorner; Bruce D. Gaylinn; Kevin R. Lynch; Jeffrey K. Harrison
Archive | 1992
Michael O. Thorner; Bruce D. Gaylinn; John Ronald Zysk; Kevin R. Lynch; Jeffrey K. Harrison
Archive | 1993
Michael O. Thorner; Bruce D. Gaylinn; John Ronald Zysk; Cecil Mark Eppler
Archive | 1995
Michael O. Thorner; Bruce D. Gaylinn; Jeffrey K. Harrison; Kevin R. Lynch; John Ronald Zysk
Archive | 1993
Michael O. Thorner; Bruce D. Gaylinn; John Ronald Zysk; Kevin R. Lynch; Jeffrey K. Harrison
Archive | 1993
Michael O. Thorner; Bruce D. Gaylinn; John Ronald Zysk; Cecil Mark Eppler